| Year |
Citation |
Score |
| 2023 |
Miljanic M, Nwachukwu C, Rahimi A. Definitive ablative stereotactic partial breast irradiation in early stage inoperable breast cancer. Journal of Cancer Research and Clinical Oncology. PMID 37648809 DOI: 10.1007/s00432-023-05053-x |
0.322 |
|
| 2023 |
Johns C, Yen A, Rahimi A, Liu YL, Leitch AM, Spangler A, Alluri P, Nwachukwu C, Wooldridge R, Farr D, Kim DWN. Aspirin Use Is Associated With Improved Outcomes in Inflammatory Breast Cancer Patients. Journal of Breast Cancer. 26: 14-24. PMID 36762783 DOI: 10.4048/jbc.2023.26.e3 |
0.364 |
|
| 2022 |
Zhang-Velten E, Zhang Y, Radpour S, Gu X, Kim DN, Alluri P, Nwachukwu C, Chiu T, Lu W, Parsons D, Tan J, Gillespie J, Stevenson S, Choy H, Timmerman R, et al. A How-To Compendium for GammaPod Treatments, Clinical Workflow, and Clinical Program at an Early Adopting Institution. Practical Radiation Oncology. PMID 35150897 DOI: 10.1016/j.prro.2022.01.006 |
0.331 |
|
| 2019 |
Nwachukwu C, Baskovic M, Fujimoto D, Von-Eyben R, English DP, Kidd E. Clinicopathologic factors associated with increased risk of recurrence in stage IA grade 1 endometrial cancer Gynecologic Oncology. 154. DOI: 10.1016/J.Ygyno.2019.03.223 |
0.311 |
|
| 2018 |
Harris JP, Nwachukwu C, Qian Y, Pollom E, Loo BW, Das M, Diehn M. Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 124: 76-85. PMID 30268484 DOI: 10.1016/J.Lungcan.2018.07.033 |
0.352 |
|
| 2015 |
Poli E, Zhang J, Nwachukwu C, Zheng Y, Adedokun B, Olopade OI, Han YJ. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter. Plos One. 10: e0142224. PMID 26539832 DOI: 10.1371/Journal.Pone.0142224 |
0.448 |
|
| 2014 |
Bockhorn J, Prat A, Chang YF, Liu X, Huang S, Shang M, Nwachukwu C, Gomez-Vega MJ, Harrell JC, Olopade OI, Perou CM, Liu H. Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer models. Cancer Research. 74: 7406-17. PMID 25339353 DOI: 10.1158/0008-5472.Can-14-1188 |
0.476 |
|
| 2013 |
Bockhorn J, Dalton R, Nwachukwu C, Huang S, Prat A, Yee K, Chang YF, Huo D, Wen Y, Swanson KE, Qiu T, Lu J, Young Park S, Eileen Dolan M, Perou CM, et al. MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11 Nature Communications. 4. PMID 23340433 DOI: 10.1038/Ncomms2393 |
0.444 |
|
| 2013 |
Bockhorn J, Yee K, Chang YF, Prat A, Huo D, Nwachukwu C, Dalton R, Huang S, Swanson KE, Perou CM, Olopade OI, Clarke MF, Greene GL, Liu H. MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion Breast Cancer Research and Treatment. 137: 373-382. PMID 23224145 DOI: 10.1007/S10549-012-2346-4 |
0.485 |
|
| 2013 |
Liu H, Bockhorn J, Dalton R, Nwachukwu C, Huang S, Prat A, Yee K, Chang Y, Huo D, Lu J, Dolan E, Perou CM, Olopade OI, Clarke MF, Greene G. Abstract 832: MicroRNA-30c inhibits human breast tumor chemo-resistance by regulating twinfinlin-1 (TWF1) and IL-11. Cancer Research. 73: 832-832. DOI: 10.1158/1538-7445.Am2013-832 |
0.443 |
|
| 2013 |
Bockhorn J, Yee K, Chang Y, Prat A, Huo D, Nwachukwu C, Dalton R, Huang S, Swanson KE, Perou CM, Olufunmilayo OI, Clarke MF, Liu H, Greene G. Abstract 5337: MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion. Cancer Research. 73: 5337-5337. DOI: 10.1158/1538-7445.Am2013-5337 |
0.489 |
|
| 2012 |
Weigman VJ, Chao HH, Shabalin AA, He X, Parker JS, Nordgard SH, Grushko T, Huo D, Nwachukwu C, Nobel A, Kristensen VN, Børresen-Dale AL, Olopade OI, Perou CM. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival. Breast Cancer Research and Treatment. 133: 865-80. PMID 22048815 DOI: 10.1007/S10549-011-1846-Y |
0.413 |
|
| 2012 |
Liu H, Bockhorn J, Dalton R, Nwachukwu C, Prat A, Yee K, Huang S, Swanson K, Perou CM, Olopade OI, Clarke MF, Greene GL. Abstract 3331: MicroRNAs regulate breast cancer stem cells and spontaneous metastases in orthotopic xenograft models Cancer Research. 72: 3331-3331. DOI: 10.1158/1538-7445.Am2012-3331 |
0.448 |
|
| 2010 |
Xu J, Huo D, Chen Y, Nwachukwu C, Collins C, Rowell J, Slamon DJ, Olopade OI. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors Breast Cancer Research and Treatment. 120: 593-601. PMID 19466541 DOI: 10.1007/S10549-009-0422-1 |
0.32 |
|
| 2010 |
Grushko TA, Nwachukwu C, Charoenthammaraksa S, Huo D, Khramtsov A, Mashek H, Zhang C, Xu J, Perou CM, Olopade OI. Evaluation of BRCA1 inactivation by promoter methylation as a marker of triple-negative and basal-like breast cancers. Journal of Clinical Oncology. 28: 10510-10510. DOI: 10.1200/Jco.2010.28.15_Suppl.10510 |
0.463 |
|
| 2010 |
Nwachukwu C, Zhang C, Duan S, Huo D, Minn A, Perou C, Olopade O. Abstract 3004: Specific microRNAs associate with aggressive breast tumor phenotypes in an ethnically diverse patient cohort Cancer Research. 70: 3004-3004. DOI: 10.1158/1538-7445.Am10-3004 |
0.427 |
|
| 2009 |
Nwachukwu C, Grushko T, Xu J, Khramtsov A, Olopade O. BRCA1 methylation contributes to the triple-negative breast cancer phenotype. Cancer Research. 69: 4050. DOI: 10.1158/0008-5472.Sabcs-4050 |
0.477 |
|
| Show low-probability matches. |